Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
10X Genomics Inc (10X Genomics) is a life science technology company that develops innovative genomics platforms. It offers a chromium single cell platform which includes microfluidic chips, consumables, and the Chromium X Series and legacy chromium instruments for single-cell analysis, enabling researchers to perform transcriptomic profiling and multiomic studies to understand human disorders. 10X Genomics offers a Visium Spatial platform, designed for spatial gene expression analysis. It also offers Xenium In Situ, targets in tissue sections with single cell spatial imaging. It serves academic and translational researchers and biopharmaceutical companies. The company operates in the North America, Asia, and Europe. 10X Genomics is headquartered in Pleasanton, California, the US.
Products and Services
| Products | Services |
|---|---|
| Platform: | Technical Assistance and Training |
| Chromium Single Cell: | |
| Universal 3' Gene Expression | |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Acquisitions/Mergers/Takeovers | In June, the company acquired the Proteintech Genomics division from Proteintech Group. |
| 2026 | New Products/Services | In April, the company launched Atera, a new in situ spatial biology platform. |
| 2026 | Contracts/Agreements | In January, the company partnered with CareDx Inc. to launch ImmuneScape, a multiomics research initiative. |
Competitor Comparison
| Key Parameters | 10X Genomics Inc | Illumina Inc | Standard BioTools Inc | Akoya Biosciences Inc | Parse Biosciences Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Pleasanton | San Diego | Boston | Marlborough | Seattle |
| State/Province | California | California | Massachusetts | Massachusetts | Washington |
| No. of Employees | 1,178 | 8,600 | 385 | 205 | - |
| Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| John R. Stuelpnagel | Chairman | Executive Board | 2013 | 68 |
| Serge Saxonov, Ph.D. | Chief Executive Officer; Director | Executive Board | 2012 | 49 |
| Benjamin J. Hindson, Ph.D. | Director; Chief Scientific Officer; President | Executive Board | 2012 | 51 |
| Adam S. Taich | Chief Financial Officer | Senior Management | 2024 | 51 |
| Michael Schnall-Levin | Chief Strategy Officer; Chief Technology Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer